Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing
Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
Who this might be right for
Rheumatoid Arthritis
CSL Behring 418